Sottoriva and colleagues combine next-generation sequencing and AI-aided histopathology to assess tumor evolvability in patient samples with long-term follow-up and find that it can be a strong predictor of recurrence in high-risk prostate cancer.
- Javier Fernandez-Mateos
- George D. Cresswell
- Andrea Sottoriva
